Dr. Kevin Kavookjian, MD

Dr. Kavookjian practices at New Jersey Behavioral Health P.C in Walnut Creek, California.

Dr. Kavookjian's NPI, 1235301706, was assigned on March 25, 2008. Dr. Kavookjian holds Maine license MD17781.

Dr. Kavookjian's primary practice is New Jersey Behavioral Health P.C, at 2970 Camino Diablo, Walnut Creek, CA 94597 in Contra Costa County. The practice phone is (732) 982-2888.

Dr. Kavookjian's primary practice is New Jersey Behavioral Health P.C in Walnut Creek, California. The medical group on file is Portrait Health Centers, Princeton, NJ. Dmand AI also links Dr. Kavookjian to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kavookjian practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Kavookjian's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dmand AI has Dr. Kavookjian's licenses on file in 2 states: Maine and New York.

CMS data shows 550 Medicare services from Dr. Kavookjian across 3 procedure codes in 2024, for 59 Medicare patients. Medicare paid $45,706 for them. Every service was in an office.

CMS counts 59 Medicare patients who saw Dr. Kavookjian in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have anxiety, and 75% have high cholesterol. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kavookjian's median patient age at 45, with 54% women.

In 2024, Dr. Kavookjian wrote 916 Medicare Part D claims for 102 patients. 92% of them were for generic drugs. CMS names the drug for 753 of them, across 25 drugs with 11 or more claims each, at $23,984 in total drug cost. In 2023, CMS named 90 claims across 6 drugs.

Dr. Kavookjian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kavookjian as offering telehealth.

CMS Open Payments shows 6 general payments to Dr. Kavookjian from 3 drug and device companies from 2020 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $125.